Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. This was a notable success — but what if we combined the insights and resources of a life science company and health provider that were both focused on, say, acute cardiovascular diseases?

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

AUGUST 8, 2012

Danny Boyle acknowledged them as the key to the success of the opening ceremony. Of course, we sometimes see such passion in the business world, in the wild enthusiasms of R&D professionals in innovative engineering and pharmaceutical companies. They are all over the Games. They greet you at the airport.

Pharmaceuticals 17

Pharmaceuticals Wilde Fashion Engineering 17

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. I''ll describe both, but first let''s look at what''s wrong with some of the traditional sources of innovation.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

NOVEMBER 1, 2017

Its success demonstrates the potential of digital health services, and its approach can serve as a model for applying such services to other chronic diseases. The course usually consists of weekly sessions during the initial four months.

Health Care 14

Health Care Participative Wireless Pharmaceuticals 14

Harvard Business Review

JANUARY 10, 2014

Think about what happens in mergers, at least in the successful ones. By one insider’s account, recent mergers among big pharmaceutical firms led to R&D cutbacks and reduced productivity. Business combinations on a smaller scale are often more successful than big mergers. I’ll extend that idea to business. Author included.).

Restructuring 8

Restructuring Trends Long-term Short-term 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. The megatrend in demand, of course, is the shift to developing economies.

Globalization 10

Globalization Supply Chain Pharmaceuticals McKinsey 10

Harvard Business Review

MARCH 11, 2013

So why is it that the most successful corporation on the planet in this new millennium has been a secretive hierarchy run by a (now-deceased) tyrant? Williams , Radical Openness: Four Unexpected Principles for Success. It's more open than most observers note, and that's been at the heart of much of its success.

Supply Chain 16

Supply Chain Open-book Software Niche Marketing 16

Harvard Business Review

MARCH 2, 2012

HBS welcomes 6,360 foreign nationals (64% of the total) to its executive education courses each year, enriching the experiences for Americans as well. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 14

Competitive Advantage Globalization Development Intellectual Capital 14

Harvard Business Review

OCTOBER 13, 2014

When we think that a particular course of action is the correct decision, our human tendency is to interpret any available information as supportive of that course of action. Say you introduce an innovative new customer-relationship-management (CRM) tool for your sales force, and revenue increases by 15%. Maybe or maybe not.

Flextime 13

Flextime Call Center Human Resources CRM 13

Harvard Business Review

MAY 17, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). OK, you know I have to say it: Of course this scandal boils down to a massive management problem. Will Online Courses Really Improve the Productivity of Higher Ed? Just Add Training! New Yorker.

Pharmaceuticals 8

Pharmaceuticals Course Middle Management Training 8

Harvard Business Review

JANUARY 30, 2014

No major and widely embraced employee productivity enhancement initiative has veered farther off course than wellness. By cutting spending on failed wellness conventions, organizations will find room in the budget for wellness innovations that will raise morale by doing things for employees instead of to them. Health Human resources'

Human Resources 11

Human Resources Guidelines Morale Insurance 11

Harvard Business Review

SEPTEMBER 26, 2011

The conventional course of action would have been to cut investments in research and restructure. Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. Yes, those actions would have boosted short-term earnings. I disagree.

CEO 16

CEO Short-term Long-term Restructuring 16

Harvard Business Review

MARCH 11, 2013

So why is it that the most successful corporation on the planet in this new millennium has been a secretive hierarchy run by a (now-deceased) tyrant? Williams , Radical Openness: Four Unexpected Principles for Success. It's more open than most observers note, and that's been at the heart of much of its success.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. To account for its success, many point to America’s entrepreneurial culture, its tolerance for failure and its unique ecosystem of venture funding. Those factors do play important roles, but the most important thing driving America’s success has been its unparalleled scientific leadership.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

SEPTEMBER 3, 2013

Hilde Dach, the former chief scientist at drug-development start-up Genbac and now a team leader at German pharmaceuticals maker Caliska, which had acquired Genbac, could read disappointment in the face of Johan Greve, the Caliska division head who was her boss. You''ve always seen it as a pharmaceutical product. Hilde turned away.

Case Study 8

Case Study Pharmaceuticals Bottom-up Marketing 8

Harvard Business Review

NOVEMBER 20, 2015

Although big, global supply chains certainly have their own dynamism, they mostly evolve incrementally through minnovation rather than disruption – and thus get short shrift in the business media and amongst aspiring entrepreneurs, hungry to create successful ventures. Manage culture by setting expectations appropriately.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

NOVEMBER 2, 2018

And in recent years, employers have enjoyed some success in controlling rising health care costs. Much of this success seems attributable to the spread of high-deductible health plans (HDHPs), which have shifted more of the costs of care onto employees. The first challenge is lack of purchasing power.

Health Care 8

Health Care Cost Insurance Price 8

Harvard Business Review

NOVEMBER 7, 2012

Innovation is one those evergreen themes: it is a rare CEO who doesn't list innovation as one her top four or five priorities. But innovation is an elusive beast. We can look to companies renowned for innovation — like Apple and Google — and try to learn from them. So what to do? But that's a flawed approach.

Company 9

Company Stage-Gate Innovation Bureaucracy 9

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. A hallmark of the successful 32% was the involvement of mid-level managers two or more levels below the CEO.

Middle Management 15

Middle Management Six Sigma Taylorism Taylor 15

Harvard Business Review

NOVEMBER 28, 2017

Doing so entails operating more efficiently or innovating to create products that consumers value more. Of course, markets are imperfect. Touting profitability may impress investors who understand it as an indication of efficiency and innovation in the face of adversity. The good news?

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

MAY 10, 2013

Its RAZR thin phone was a huge success in the mid-2000''s, and the market raved. The next few product launches were not nearly as successful and Ed Zander , a CEO who came in during the successful period, was unable to come up with any more hits. Competition Disruptive innovation Strategy' Take Motorola, for instance.

Venture Capitalist 9

Venture Capitalist Restructuring Competitive Advantage Short-term 9

Harvard Business Review

MARCH 8, 2011

It is your legacy you're looking for; a generic or tradition-bound view of success won't suffice. Lafley became the CEO of Procter & Gamble, he saw that the company's current expansion strategy, which had put it in markets as diverse as pharmaceuticals and snack foods, would continue to erode value. But the rewards are profound.

Merchandising 15

Merchandising Budgeting Pharmaceuticals CEO 15

Harvard Business Review

JUNE 24, 2015

The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea. This approach has helped Mars build itself into a profitable $35 billion company and multi-category leader over the course of a century.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

MAY 25, 2017

How the most innovative providers are creating value. While new EHR offerings continue to emerge, the market has consolidated around a few large players, which has held back innovation and interoperability. Uncertainty surrounding the health care bill shouldn’t have a material effect on the success of various solutions.

Health Care 10

Health Care Trends Venture Funding Technology 10

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 15

Price Pharmaceuticals Company Health Care 15